Skip to main content

Site notifications

GLYCOPHOS (Fresenius Kabi Australia Pty Ltd)

Product name
GLYCOPHOS
Date registered
Evaluation commenced
Decision date
Approval time
199 working days (255)
Active ingredients
sodium glycerophosphate hydrate
Registration type
NCE/NBE
Indication

GLYCOPHOS (concentrated solution for injection) is indicated in adult and paediatric patients as a supplement to parenteral nutrition to meet the daily requirements of phosphate.

Help us improve the Therapeutic Goods Administration site